Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dalfampridine1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
2Daraprim1件: Pyrimethamine1件: Pyrimethamine 💬 --2件: 2, 4 💬
3Dexdor1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 2, 4, 6, 70 💬
4Dexmedetomidine1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
5Esketamine1件: Esketamine2件: Esketamine ,
Esketamine hydrochloride 💬 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬5件: 2, 4, 6, 96, 97 💬
6HB-admscs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---7件: 2, 4, 6, 13, 14, 46, 49 💬
7Ketanest-S----3件: 2, 4, 70 💬
8Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
9Pyrimethamine1件: Pyrimethamine1件: Pyrimethamine 💬 --4件: 2, 4, 19, 65 💬
10Stem cells----5件: 2, 4, 46, 96, 113 💬